PEAK6’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Sell
4,500
-35,800
-89% -$3.13M ﹤0.01% 2050
2026
Q1
$3.43M Buy
+40,300
New +$3.59M 0.01% 1083
2025
Q3
– Sell
-11,900
Closed -$1.08M – 2992
2025
Q2
$1.08M Sell
11,900
-112,600
-90% -$10.3M ﹤0.01% 1764
2025
Q1
$11.7M Buy
124,500
+105,700
+562% +$9.46M 0.03% 521
2024
Q4
$1.71M Buy
+18,800
New +$1.79M ﹤0.01% 1509

Other funds holding CL

PEAK6's CL Position: Q2 2026 in Review

PEAK6 opened a new position in Colgate-Palmolive (CL) in Q2 2026: 2,884 shares worth $264K. The stake represents ﹤0.01% of the portfolio and ranks #2194 among its holdings. This is a return to the name: PEAK6 previously reported a position in CL as recently as Q4 2025.

PEAK6 first reported a position in CL in Q4 2025 and has held it in 2 quarters since. The position peaked at $619K in Q4 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • PEAK6 held 2,884 shares of Colgate-Palmolive worth $264K as of Q2 2026.
  • Colgate-Palmolive was a new PEAK6 position in Q2 2026.
  • Colgate-Palmolive made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2194 holding.
  • PEAK6 first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 2 quarters since.
  • PEAK6's Colgate-Palmolive position peaked at $619K in Q4 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.